Sheela Foam Limited has informed the Exchange about Investor Presentation
SFL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sheela Foam reported Q4 FY25 consolidated revenue of INR 850 Cr, up just 1% YoY, while EBITDA fell 15% YoY to INR 69 Cr with margins contracting to 8.1%. FY25 consolidated revenue grew 15% to INR 3,439 Cr, supported by the Kurlon (KEL) acquisition, but EBITDA declined 5% to INR 286 Cr. Net profit for FY25 dropped sharply to INR 97 Cr from INR 184 Cr the previous year, with diluted EPS halving to INR 8.8. Finance costs more than doubled YoY on consolidated basis (INR 121 Cr vs INR 69 Cr), reflecting higher borrowings tied to acquisitions. Segment-wise, mattress volumes rose strongly to 3,308 K units in FY25, while Australia and Spain operations also saw EBITDA margin compression in Q4.
Despite healthy top-line growth driven by acquisitions, shareholders face significant margin and bottom-line pressure with EBITDA margins sliding from 11% to 9% standalone and PAT nearly halving. Rising finance costs and elevated debt levels (current borrowings of INR 500 Cr standalone) raise concerns about near-term profitability, which could weigh on the stock in the short term.